Compounds > fulvestrant
Page last updated: 2024-08-26

fulvestrant and trichostatin a

fulvestrant has been researched along with trichostatin a in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's7 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bilter, GK; Dias, J; Huang, Z; Keon, BH; Lamerdin, J; MacDonald, ML; Michnick, SW; Minami, T; Owens, S; Shang, Z; Westwick, JK; Yu, H1
Davidson, NE; Ferguson, AT; Herman, JG; Nelson, WG; Phillips, DL; Yang, X1
Cross, HS; Farhan, H; Wähälä, K1
Balaguer, P; Bonnet, S; Cavaillès, V; Duong, V; Escande, A; Margueron, R; Vignon, F1
Alao, JP; Ali, S; Coombes, RC; Halim, F; Hart, SM; Lam, EW; Madureira, PA; Sunters, A; Varshochi, R; Vigushin, DM1
Guo, SW; Wu, Y1
Hyttinen, JM; Kaarniranta, K; Kyrylenko, S; Ojala, J; Salminen, A; Suuronen, T; Thornell, A1

Other Studies

7 other study(ies) available for fulvestrant and trichostatin a

ArticleYear
Identifying off-target effects and hidden phenotypes of drugs in human cells.
    Nature chemical biology, 2006, Volume: 2, Issue:6

    Topics: Bacterial Proteins; Cell Line; Cell Proliferation; Cluster Analysis; Drug Design; Drug Evaluation, Preclinical; Genetics; Humans; Luminescent Proteins; Molecular Structure; Phenotype; Recombinant Fusion Proteins; Signal Transduction; Structure-Activity Relationship

2006
Synergistic activation of functional estrogen receptor (ER)-alpha by DNA methyltransferase and histone deacetylase inhibition in human ER-alpha-negative breast cancer cells.
    Cancer research, 2001, Oct-01, Volume: 61, Issue:19

    Topics: Acetylation; Azacitidine; Breast Neoplasms; CpG Islands; Decitabine; DNA (Cytosine-5-)-Methyltransferase 1; DNA (Cytosine-5-)-Methyltransferases; DNA Methylation; Drug Synergism; Enzyme Inhibitors; Estradiol; Estrogen Antagonists; Estrogen Receptor alpha; Fulvestrant; Gene Expression Regulation, Neoplastic; Histone Deacetylase Inhibitors; Histones; Humans; Hydroxamic Acids; Receptors, Estrogen; RNA, Messenger; Tumor Cells, Cultured

2001
Genistein inhibits vitamin D hydroxylases CYP24 and CYP27B1 expression in prostate cells.
    The Journal of steroid biochemistry and molecular biology, 2003, Volume: 84, Issue:4

    Topics: 25-Hydroxyvitamin D3 1-alpha-Hydroxylase; Cell Division; Chromatography, High Pressure Liquid; Cytochrome P-450 Enzyme Inhibitors; Enzyme Inhibitors; Estradiol; Estrogen Antagonists; Estrogens, Non-Steroidal; Fulvestrant; Genistein; Histone Deacetylases; Humans; Hydroxamic Acids; Isoflavones; Male; Phytoestrogens; Plant Preparations; Prostatic Neoplasms; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Steroid Hydroxylases; Time Factors; Transcription, Genetic; Tumor Cells, Cultured; Vitamin D; Vitamin D3 24-Hydroxylase

2003
Histone deacetylase inhibition and estrogen receptor alpha levels modulate the transcriptional activity of partial antiestrogens.
    Journal of molecular endocrinology, 2004, Volume: 32, Issue:2

    Topics: Breast Neoplasms; Enzyme Inhibitors; Estradiol; Estrogen Receptor alpha; Estrogen Receptor beta; Estrogen Receptor Modulators; Female; Fulvestrant; Genes, Reporter; Histone Deacetylase Inhibitors; Humans; Hydroxamic Acids; Pyrrolidines; Raloxifene Hydrochloride; Response Elements; Tamoxifen; Thiophenes; Transcription, Genetic; Tumor Cells, Cultured

2004
ICI182,780 induces p21Waf1 gene transcription through releasing histone deacetylase 1 and estrogen receptor alpha from Sp1 sites to induce cell cycle arrest in MCF-7 breast cancer cell line.
    The Journal of biological chemistry, 2005, Feb-04, Volume: 280, Issue:5

    Topics: Antineoplastic Agents, Hormonal; Binding Sites; Breast Neoplasms; Cell Cycle Proteins; Cell Line, Tumor; Cyclin-Dependent Kinase Inhibitor p21; Enzyme Inhibitors; Estradiol; Estrogen Receptor alpha; Fulvestrant; G1 Phase; Gene Silencing; Histone Deacetylase Inhibitors; Histone Deacetylases; Humans; Hydroxamic Acids; Promoter Regions, Genetic; RNA, Small Interfering; Sp1 Transcription Factor; Transcriptional Activation; Up-Regulation

2005
Inhibition of proliferation of endometrial stromal cells by trichostatin A, RU486, CDB-2914, N-acetylcysteine, and ICI 182780.
    Gynecologic and obstetric investigation, 2006, Volume: 62, Issue:4

    Topics: Acetylcysteine; Cell Line; Cell Proliferation; Dose-Response Relationship, Drug; Endometriosis; Endometrium; Enzyme Inhibitors; Estradiol; Fas Ligand Protein; fas Receptor; Female; Fulvestrant; Humans; Hydrogen Peroxide; Hydroxamic Acids; Mifepristone; Norpregnadienes; Receptors, Androgen; Receptors, Estrogen; Receptors, Progesterone; RNA, Messenger; Stromal Cells

2006
Regulation of ER alpha signaling pathway in neuronal HN10 cells: role of protein acetylation and Hsp90.
    Neurochemical research, 2008, Volume: 33, Issue:9

    Topics: Acetylation; Animals; Benzoquinones; Cell Line; Dactinomycin; Dehydroepiandrosterone; Diethylstilbestrol; Enzyme Inhibitors; Estradiol; Estrogen Antagonists; Estrogen Receptor alpha; Estrogens; Estrogens, Non-Steroidal; Fulvestrant; Genes, Reporter; Histone Deacetylase Inhibitors; Histone Deacetylases; HSP90 Heat-Shock Proteins; Humans; Hydroxamic Acids; Lactams, Macrocyclic; Neurons; Protein Synthesis Inhibitors; Selective Estrogen Receptor Modulators; Signal Transduction; Sirtuin 2; Sirtuins; Transcriptional Activation; Valproic Acid

2008